These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 33405944

  • 1. MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus.
    Durand R, Reid JR, Belasco JB, Shellikeri S, Calle-Toro JS, Cahill AM, Srinivasan A.
    AJR Am J Roentgenol; 2021 Sep; 217(3):741-752. PubMed ID: 33405944
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of sirolimus in the treatment of complex lymphatic malformations: Single center report of 56 cases.
    Tian R, Liang Y, Zhang W, Wang J, Shan Y, Gao H, Xie C, Li J, Xu M, Gu S.
    J Pediatr Surg; 2020 Nov; 55(11):2454-2458. PubMed ID: 32044101
    [Abstract] [Full Text] [Related]

  • 3. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M, Nozawa A, Yasue S, Endo S, Asada R, Hashimoto H, Fukao T.
    Orphanet J Rare Dis; 2019 Jun 13; 14(1):141. PubMed ID: 31196128
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of Initial Sirolimus Therapy for 27 Patients with Intractable Lymphatic Malformations.
    Zhang X, Wang S, Guo Y, Liu Y, Zhang J, Li Y, Liu Q, Liu Z, Sun N, Li X, Liu Y, Du J, Cheng X, Wang X, Tai J, Ni X.
    Laryngoscope; 2021 Aug 13; 131(8):1902-1908. PubMed ID: 33571378
    [Abstract] [Full Text] [Related]

  • 5. Use of topical rapamycin in the treatment of superficial lymphatic malformations.
    García-Montero P, Del Boz J, Baselga-Torres E, Azaña-Defez JM, Alcaraz-Vera M, Tercedor-Sánchez J, Noguera-Morel L, Vera-Casaño Á.
    J Am Acad Dermatol; 2019 Feb 13; 80(2):508-515. PubMed ID: 30296533
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review.
    Wiegand S, Wichmann G, Dietz A.
    Lymphat Res Biol; 2018 Aug 13; 16(4):330-339. PubMed ID: 29924669
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
    Le Sage S, David M, Dubois J, Powell J, McCuaig CC, Théorêt Y, Kleiber N.
    Pediatr Dermatol; 2018 Jul 13; 35(4):472-477. PubMed ID: 29790593
    [Abstract] [Full Text] [Related]

  • 9. Airway response to sirolimus therapy for the treatment of complex pediatric lymphatic malformations.
    Alemi AS, Rosbe KW, Chan DK, Meyer AK.
    Int J Pediatr Otorhinolaryngol; 2015 Dec 13; 79(12):2466-9. PubMed ID: 26549380
    [Abstract] [Full Text] [Related]

  • 10. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
    Maruani A, Boccara O, Bessis D, Guibaud L, Vabres P, Mazereeuw-Hautier J, Barbarot S, Chiaverini C, Blaise S, Droitcourt C, Mallet S, Martin L, Lorette G, Woillard JB, Jonville-Bera AP, Rollin J, Gruel Y, Herbreteau D, Goga D, le Touze A, Leducq S, Gissot V, Morel B, Tavernier E, Giraudeau B, Groupe de Recherche de la Societé Française de Dermatologie Pédiatrique.
    Trials; 2018 Jun 27; 19(1):340. PubMed ID: 29945674
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
    Ricci KW, Hammill AM, Mobberley-Schuman P, Nelson SC, Blatt J, Bender JLG, McCuaig CC, Synakiewicz A, Frieden IJ, Adams DM.
    Pediatr Blood Cancer; 2019 May 27; 66(5):e27614. PubMed ID: 30672136
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation.
    Strychowsky JE, Rahbar R, O'Hare MJ, Irace AL, Padua H, Trenor CC.
    Laryngoscope; 2018 Jan 27; 128(1):269-276. PubMed ID: 28782106
    [Abstract] [Full Text] [Related]

  • 14. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
    Triana P, Miguel M, Díaz M, Cabrera M, López Gutiérrez JC.
    Lymphat Res Biol; 2019 Oct 27; 17(5):504-511. PubMed ID: 30985248
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sirolimus for Pediatric Cervicofacial Lymphatic Malformation: A Systematic Review and Meta-Analysis.
    Kamhieh Y, Mitra R, Burnett T, Jones H, Roblin G, Hall A.
    Laryngoscope; 2024 May 27; 134(5):2038-2047. PubMed ID: 37812168
    [Abstract] [Full Text] [Related]

  • 19. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.
    Alexander MD, McTaggart RA, Choudhri OA, Marcellus ML, Do HM.
    J Neurointerv Surg; 2014 Nov 27; 6(9):691-4. PubMed ID: 24153336
    [Abstract] [Full Text] [Related]

  • 20. Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.
    Badia P, Ricci K, Gurria JP, Dasgupta R, Patel M, Hammill A.
    Pediatr Blood Cancer; 2020 Apr 27; 67(4):e28088. PubMed ID: 31930696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.